Developing precision therapies for chronic inflammation, autoimmune diseases and cancer Noxopharm (ASX:NOX) Investor Presentation September 2026 1 Disclaimer This presentation has been prepared by Noxopharm Limited (Noxopharm, NOX or the Company). It should not be considered as an...